Orion Portfolio Solutions LLC Sells 2,861 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Orion Portfolio Solutions LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 86,906 shares of the healthcare conglomerate's stock after selling 2,861 shares during the period. Orion Portfolio Solutions LLC's holdings in UnitedHealth Group were worth $43,962,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $25,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter worth approximately $30,000. Promus Capital LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at $32,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group in the third quarter worth $37,000. Finally, Pillar Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth about $40,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts recently weighed in on UNH shares. Cantor Fitzgerald reissued an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Barclays dropped their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a report on Friday, January 17th. Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research note on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a research report on Tuesday, December 3rd. Finally, Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of "Buy" and an average target price of $629.32.

Remove Ads

UnitedHealth Group Price Performance

Shares of UNH traded down $0.25 on Friday, hitting $515.47. The company's stock had a trading volume of 2,378,211 shares, compared to its average volume of 4,268,981. The company has a 50 day moving average price of $508.81 and a 200 day moving average price of $544.24. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a market capitalization of $471.51 billion, a PE ratio of 33.26, a PEG ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the company earned $5.83 EPS. The firm's quarterly revenue was up 6.8% on a year-over-year basis. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.63%. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.19%.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.33% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.